Commercial microbial identification systems rank the relative likelihood of species identity on the basis of in vitro reactions only. Failure to consider the prevalence of individual taxa results in a spurious demotion of common species; and a tendency toward over reporting of rare microbes. The incorporation of Bayesian analysis into identification matrices can provide for a realistic ranking of bacterial species which fulfil given biocode schemes.
No takes yet. Share an insight, caveat, or question.
Sebastian Berger (1990) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: